PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New evidence sheds light on treatment for patients with respiratory failure from COVID-19

Findings suggest ECMO life-support therapy can improve odds of survival for patients critically ill with COVID-19

2021-02-02
(Press-News.org) Boston, Mass. - COVID-19 has caused more than 2 million deaths worldwide since the World Health Organization declared it a pandemic in March 2020. Patients with severe COVID-19 frequently experience respiratory distress and require assistance breathing. For patients whose lungs are so injured that even a ventilator is unable to deliver enough oxygen, extracorporeal membrane oxygenation (ECMO) -- which does the work of the lungs by removing carbon dioxide and adding oxygen to blood outside the body -- may improve the odds of survival for certain patients with severe COVID-19.

A study by physician-researchers at Beth Israel Deaconess Medical Center (BIDMC) and Brigham and Women's Hospital (BWH) provides new evidence that critically ill patients with COVID-19 who were treated with ECMO had better odds of survival than those who were not treated with ECMO. The findings -- published in Intensive Care Medicine [LINK] -- represent the only published study to investigate ECMO's efficacy for treatment of critically ill patients with COVID-19.

"ECMO gives patients' lungs time to heal when we've exhausted every other aspect of care for these patients -- it can be a bridge to recovery," said corresponding author Shahzad Shaefi, MD, Co-Director of the ECMO Program at BIDMC and in the Department of Anesthesia, Critical Care and Pain Medicine. "But ECMO's efficacy in the context of COVID-19 remains unclear. This work sheds new light on that question in the most robust way possible during the COVID-19 pandemic."

The team analyzed observational data from Study of the Treatment and Outcomes in Critically Ill Patients with COVID-19 (STOP-COVID), a multicenter cohort study of patients with COVID-19 admitted to intensive care units at 68 hospitals across the United States. Spearheaded in March 2020 by senior author David E. Leaf, MD, Director of Clinical and Translational Research in Acute Kidney Injury in the Division of Renal Medicine at the Brigham, the STOP-COVID dataset includes more than 5,000 critically ill adult patients and depended on a dedicated volunteer workforce to collect more than 800 individual data elements per patient, all by manual chart review.

"This was a remarkable grassroots effort involving more than 400 research assistants, medical students, residents, fellows, and attendings across the United States collecting this data manually during the height of the pandemic," said Leaf, who is also Assistant Professor of Medicine at Harvard Medical School. "People were highly motivated to get this database assembled, as it represents the best data we have about critically ill patients with COVID-19 in this country."

Overall, the scientists found that 190 of the 5,122 critically ill adults (3 percent) admitted to the ICU with COVID-19 between March 1 and July 1, 2020, received treatment with ECMO. Among those 190 patients, nearly 70 percent survived to hospital discharge or at least 60 days following ICU admission.

Next, Shaefi, Leaf and colleagues delved deeper into the data using an analytic technique called target trial emulation, which allows researchers to use observational data to infer causality when randomized controlled trials are unavailable. By this method, the researchers examined selected patients with severe respiratory failure, defined as those with a very low ratio of oxygen content in their blood divided by the amount of inspired oxygen delivered by the ventilator. They found that patient treated with ECMO in the first seven days of ICU admission had a considerable reduction in mortality compared to those who were similarly ill but who were not treated with ECMO. Specifically, among the 1,297 patients eligible for the target trial emulation, just over a third of the 130 who received ECMO died, compared to nearly half of those who did not receive ECMO.

"These findings are not only statistically significant, but very clinically meaningful," said Leaf. "They show a considerable magnitude of benefit with ECMO - a 45 percent reduction in death - among the sickest patients. That's very compelling evidence that ECMO saves lives."

"The real question with ECMO is, are we saving lives, or -- candidly -- are we prolonging poor outcomes and death," said Shaefi, who is also Assistant Professor in Anesthesia at Harvard Medical School. "The benefit of ECMO prevailed across all of our analyses. In the absence of a randomized controlled trial, which traditionally been very difficult to cleanly do in ECMO, this work represents perhaps the best current evidence we have of the role of ECMO in treating select critically ill COVID 19 patients."

INFORMATION:

In addition to Shaefi and Leaf, co-authors included, Brian P. O'Gara and Megan L. Krajewski of BIDMC; Shruti Gupta, Tanveer Shaukat, Harkarandeep Singh, and Wei Wang of BWH. Please see the publication for a complete list of authors and affiliations.

This study is unfunded work. DEL received research support from BioPorto outside the submitted work. SG is a scientific coordinator for the ASCEND trial (GlaskoSmithKline), outside the submitted work. BOG receives consulting fees from Sedana Medical outside the submitted work. Please see the paper for a complete list of author disclosures.

The authors of the writing committee are supported by the following grants from the National Institute of Health (grants K08GM134220 and R03AG060179 (SS); R01HL144566 and R01DK125786 (DEL); K23HL130648 (KSM); R37 AI102634 (MAH); F32DC017342 (SG); K23DK120811(AS); K23HL143053 (MWS).



ELSE PRESS RELEASES FROM THIS DATE:

Harvard researchers use machine learning models to study health impacts of walnuts

2021-02-02
FOLSOM, Calif., February 2, 2021 - Researchers, from the Harvard T.H. Chan School of Public Health in collaboration with investigators from Rovira i Virgili University and the University of Navarra, Spain, used machine learning models, a subset of artificial intelligence, to identify more precisely the components in walnuts that may be responsible for potentially reducing the risk of type 2 diabetes and cardiovascular diseases - two of the leading causes of death in the U.S. This study, supported by the California Walnut Commission and published in the Journal of Nutrition, used a novel machine learning model to identify 19 metabolites that were associated with walnut consumption. The body forms specific metabolites based on what food is consumed. The walnut ...

Study aims to break the chains of incarceration in African American males

Study aims to break the chains of incarceration in African American males
2021-02-02
Over the last three decades, the United States prison population has exploded from 300,000 to more than 2 million. More than 1.1 million are African American men - the vast number of whom have returned within one to three years of their release. In fact, according to the World Prison Brief, America boasts the highest recidivism rate at more than 50 percent. Although African American men are more likely to participate in re-entry programs, they continue to struggle with recidivism and reunification at higher rates. The common conception of assisting individuals impacted by incarceration is to provide practical needs such as housing, food and employment. Often, these services are insufficient when the core of their issues is related to psychological factors. ...

Significant cancer rates in California sea lions has major human health implications

Significant cancer rates in California sea lions has major human health implications
2021-02-02
Scientists at The Marine Mammal Center - the world's largest marine mammal hospital - have found that viral-caused cancer in adult California sea lions is significantly increased by their exposure to toxins in the environment. The study is the result of over 20 years of research and examination of nearly 400 California sea lion patients by The Marine Mammal Center. The Marine Mammal Center has been on the forefront of researching and understanding cancer in California sea lions and its connection to both ocean and human health. Since the cancer in sea lions was first discovered in 1979, between 18-23 percent of adult sea lions admitted to the Center's hospital have died of the fatal disease - the ...

Big name corporations more likely to commit fraud

2021-02-02
PULLMAN, Wash. - Fortune 500 firms with strong growth profiles are more susceptible to "cooking the books" than smaller, struggling companies, according to a recent study published in Justice Quarterly. Researchers from Washington State University, Pennsylvania State University and Miami University examined the characteristics of more than 250 U.S. public corporations that were involved in financial securities fraud identified in Securities and Exchange Commission filings from 2005-2013. They were then compared to a control sample of firms that were not named in SEC fraud filings. Clear trends emerged in the risk of fraud including corporations that were listed in the Fortune 500, traded on the New York Stock Exchange and had strong growth expectations. ...

Breast cancer-on-a-chip for testing immunotherapy drugs

Breast cancer-on-a-chip for testing immunotherapy drugs
2021-02-02
(LOS ANGELES) - There are many mechanisms by which the body responds to foreign invaders. One of these involves the T-cells of the immune system, which have a number of different proteins on their surface called "checkpoint proteins." These checkpoint proteins bind to proteins on the surface of other cells and can result in either stimulation or suppression of T-cell activity. Normally, surface proteins on foreign or invading cells will produce a stimulation of T-cell activity against these cells, while T-cell suppression is a built-in mechanism to prevent the immune system from attacking the body's own normal cells. Tumor cells, ...

Child head injury guidelines created

Child head injury guidelines created
2021-02-02
Australia's and New Zealand's first set of clinical guidelines for children's head injuries has been created by a network of specialists based at the Murdoch Children's Research Institute (MCRI). The guidelines, developed by the Paediatric Research in Emergency Departments International Collaborative (PREDICT) and published in Emergency Medicine Australasia, will allow emergency department clinicians to best diagnose and treat children's head injuries while reducing unnecessary exposure to radiation from CT scans. They also address head injuries in children with underlying problems, such as a bleeding disorder. Matthew ...

Bottoms are up at the HIV Research for Prevention Virtual Conference

2021-02-02
PITTSBURGH, 2 February, 2021 - Researchers seeking to develop on-demand and behaviorally congruent HIV prevention options for people who practice anal sex are reporting the results of three early phase clinical trials of rectal microbicides at this week's HIV Research for Prevention (HIV R4P) Virtual Conference. The Phase I studies, led by the U.S. National Institutes of Health (NIH)-funded Microbicide Trials Network (MTN), found both of two gel-based products well-tolerated, with higher doses of the active drugs likely required to provide protection from HIV and other sexually transmitted infections (STIs). The results are being presented ...

A surprising cycle

A surprising cycle
2021-02-02
Hydrocarbons and petroleum are almost synonymous in environmental science. After all, oil reserves account for nearly all the hydrocarbons we encounter. But the few hydrocarbons that trace their origin to biological sources may play a larger ecological role than scientists originally suspected. A team of researchers at UC Santa Barbara and Woods Hole Oceanographic Institution investigated this previously neglected area of oceanography for signs of an overlooked global cycle. They also tested how its existence might impact the ocean's response to oil spills. "We demonstrated that there is a massive and rapid hydrocarbon cycle that occurs in the ocean, and that it is distinct from the ocean's capacity to respond to petroleum input," said Professor David Valentine(link ...

Delaying colonoscopy following abnormal stool test increases risk of colorectal cancer

Delaying colonoscopy following abnormal stool test increases risk of colorectal cancer
2021-02-02
A new Veterans Affairs study finds that delays in undergoing colonoscopy following an abnormal stool test increase the risk of a colorectal cancer diagnosis and cancer-related death. The results appeared online in the journal Gastroenterology in January 2021. In a retrospective study of more than 200,000 Veterans, the researchers found that patients who received colonoscopy more than 13 months after an abnormal stool blood test were up to 1.3 times more likely to have colorectal cancer, compared with those who had colonoscopy up to three months after the stool test. Odds of an advanced stage of cancer at diagnosis were up to 1.7 times higher when colonoscopy was delayed beyond 16 months. The findings also ...

The secrets of 3000 galaxies laid bare

2021-02-02
The complex mechanics determining how galaxies spin, grow, cluster and die have been revealed following the release of all the data gathered during a massive seven-year Australian-led astronomy research project. The scientists observed 13 galaxies at a time, building to a total of 3068, using a custom-built instrument called the Sydney-AAO Multi-Object Integral-Field Spectrograph (SAMI), connected to the 4-metre Anglo-Australian Telescope (AAT) at Siding Spring Observatory in New South Wales. The telescope is operated by the Australian National University. Overseen by the ARC Centre of Excellence for All Sky Astrophysics ...

LAST 30 PRESS RELEASES:

Emory-led Lancet review highlights racial disparities in sudden cardiac arrest and death among athletes

A new approach to predicting malaria drug resistance

Coral adaptation unlikely to keep pace with global warming

Bioinspired droplet-based systems herald a new era in biocompatible devices

A fossil first: Scientists find 1.5-million-year-old footprints of two different species of human ancestors at same spot

The key to “climate smart” agriculture might be through its value chain

These hibernating squirrels could use a drink—but don’t feel the thirst

New footprints offer evidence of co-existing hominid species 1.5 million years ago

Moral outrage helps misinformation spread through social media

U-M, multinational team of scientists reveal structural link for initiation of protein synthesis in bacteria

New paper calls for harnessing agrifood value chains to help farmers be climate-smart

Preschool education: A key to supporting allophone children

CNIC scientists discover a key mechanism in fat cells that protects the body against energetic excess

Chemical replacement of TNT explosive more harmful to plants, study shows

Scientists reveal possible role of iron sulfides in creating life in terrestrial hot springs

Hormone therapy affects the metabolic health of transgender individuals

Survey of 12 European countries reveals the best and worst for smoke-free homes

First new treatment for asthma attacks in 50 years

Certain HRT tablets linked to increased heart disease and blood clot risk

Talking therapy and rehabilitation probably improve long covid symptoms, but effects modest

Ban medical research with links to the fossil fuel industry, say experts

Different menopausal hormone treatments pose different risks

Novel CAR T cell therapy obe-cel demonstrates high response rates in adult patients with advanced B-cell ALL

Clinical trial at Emory University reveals twice-yearly injection to be 96% effective in HIV prevention

Discovering the traits of extinct birds

Are health care disparities tied to worse outcomes for kids with MS?

For those with CTE, family history of mental illness tied to aggression in middle age

The sound of traffic increases stress and anxiety

Global food yields have grown steadily during last six decades

Children who grow up with pets or on farms may develop allergies at lower rates because their gut microbiome develops with more anaerobic commensals, per fecal analysis in small cohort study

[Press-News.org] New evidence sheds light on treatment for patients with respiratory failure from COVID-19
Findings suggest ECMO life-support therapy can improve odds of survival for patients critically ill with COVID-19